“SMART” Asthma Pharmacotherapy

The GINA guidelines were updated in 2021, yet providers may not have rolled out the recent changes in practice. JAMA Clinical Guidelines Synopsis highlighted the major recommendations, including SMART therapy (single maintenance and reliever therapy) with an “A” recommendation. Join host Geoff Wall as he talks about implementing new recommendations into practice with community pharmacist and patient, Jake Galdo.The GameChanger Single Maintenance and Reliever Therapy (SMART) is the new standard in asthma management. Inhaled Corticosteroid (ICS) plus formoterol is the medication of choice for maintenance and reliever care in asthma. Show Segments 00:00 – Introductions 3:30 – Background on Asthma05:06 – GINA Guidelines on Asthma12:40 – Gamechanger: SMART Therapy17:08 - Connecting to Practice29:20 – Closing Remarks Host Geoff Wall, PharmD, BCPS, FCCP, CGP Professor of Pharmacy Practice, Drake University Internal Medicine/Critical Care, UnityPoint Health GuestJohn A. Galdo, PharmD, MBA, BCPS, BCGP (Jake)Course Content and Developer, CEimpactPharmacist, Ross Bridge PharmacyCEO, Seguridad, IncReferences and resources:Therapy for Mild to Moderate Asthma. JAMA. Global Initiative for Asthma Strategy 2021: executive summary and rationale for key changesRedeem your CPE or CME creditCPE (Pharmacist)CME (Physician) Get a membership & earn CE for GameChangers Podcast episodes (30 mins/episode) Pharmacists: Get a Membership Prescribers: Get a Membership  Continuing Education Information:Learning Objectives:1. Discuss the primary and secondary track of asthma treatment according to the GINA guidelines2. Discuss with patients why the SMART approach to using inhalers to relieve immediate symptoms is preferred.All relevant financial relationships have been mitigated.  0.05 CEU | 0.5 HrsACPE UAN: 0107-0000-22-350-H01-PInitial release date: 09/12/22Expiration date: 09/12/2023Additional CPE & CME details can be found here Follow CEimpact on Social Media:LinkedInInstagram